Dr. Nancy Rubin, DO

Dr. Rubin practices at Pacific Cancer Care in Monterey, California.

Dr. Rubin's NPI, 1003980947, was assigned on November 20, 2006. Dr. Rubin graduated from WesternU College of Osteopathic Medicine of the Pacific in 1997. Dr. Rubin holds California license 20A 7207.

Dr. Rubin's primary practice is Pacific Cancer Care, at 5 Harris Ct, Monterey, CA 93940 in Monterey County. The practice phone is (831) 375-4105.

Dr. Rubin's primary practice is Pacific Cancer Care in Monterey, California. Dr. Rubin is also affiliated with Community Hospital of the Monterey Peninsula. The medical group on file is Pacific Cancer Care. Dmand AI also links Dr. Rubin to 2 more hospitals, 2 medical groups, 1 group practice or clinic, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rubin practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Rubin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rubin is board certified in hematology by the American Board of Internal Medicine. Dr. Rubin is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Rubin treats.

CMS data shows 314,048 Medicare services from Dr. Rubin across 65 procedure codes in 2024, for 1,347 Medicare patients. Medicare paid $3,659,073 for them.

CMS counts 1,347 Medicare patients who saw Dr. Rubin in 2024. The largest group is 75 to 84, with 559 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rubin's median patient age at 73, with 72% women.

In 2024, Dr. Rubin wrote 1,071 Medicare Part D claims for 242 patients. 81% of them were for generic drugs. CMS names the drug for 673 of them, across 29 drugs with 11 or more claims each, at $1,108,370 in total drug cost. In 2023, CMS named 983 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rubin for performance year 2024, reported as part of a group. Dr. Rubin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rubin as offering telehealth.

Dmand AI links 1 paper to Dr. Rubin in 2004. Dr. Rubin's most frequent co-author is Lynda Anne Marie Szczech, MD.

Dmand AI links Dr. Rubin to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Multiple Myeloma and Blood Protein Disorders.

CMS Open Payments shows 44 general payments to Dr. Rubin from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Bristol-Myers Squibb Company paid the most, $209.

Dmand AI lists 1 award for Dr. Rubin, most recently CMS Stage 1 EHR in 2013.

Dr. Rubin graduated from WesternU College of Osteopathic Medicine of the Pacific in 1997. Dr. Rubin is a member of AOA.

Dr. Rubin is in network with 10 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Aetna. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.